246 related articles for article (PubMed ID: 29980982)
1. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: II. BSA Reconstitution and Aggregation.
Hackl E; Darkwah J; Smith G; Ermolina I
AAPS PharmSciTech; 2018 Oct; 19(7):2934-2947. PubMed ID: 29980982
[TBL] [Abstract][Full Text] [Related]
2. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
Hackl E; Darkwah J; Smith G; Ermolina I
AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
[TBL] [Abstract][Full Text] [Related]
3. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
4. Stability of lyophilized albumin formulations: Role of excipient crystallinity and molecular mobility.
Jena S; Krishna Kumar NS; Aksan A; Suryanarayanan R
Int J Pharm; 2019 Oct; 569():118568. PubMed ID: 31352055
[TBL] [Abstract][Full Text] [Related]
5. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
[TBL] [Abstract][Full Text] [Related]
6. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
7. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
[TBL] [Abstract][Full Text] [Related]
8. Radio Frequency - Assisted Ultrasonic Spray Freeze Drying for Pharmaceutical Protein Solids.
Mutukuri TT; Darwish A; Strongrich AD; Peroulis D; Alexeenko A; Zhou QT
J Pharm Sci; 2023 Jan; 112(1):40-50. PubMed ID: 36181875
[TBL] [Abstract][Full Text] [Related]
9. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
Lueckel B; Helk B; Bodmer D; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
[TBL] [Abstract][Full Text] [Related]
10. Moisture sorption behavior of selected bulking agents used in lyophilized products.
Fakes MG; Dali MV; Haby TA; Morris KR; Varia SA; Serajuddin AT
PDA J Pharm Sci Technol; 2000; 54(2):144-9. PubMed ID: 10822985
[TBL] [Abstract][Full Text] [Related]
11. Effect of Buffer Salts on Physical Stability of Lyophilized and Spray-Dried Protein Formulations Containing Bovine Serum Albumin and Trehalose.
Mutukuri TT; Ling J; Du Y; Su Y; Zhou QT
Pharm Res; 2023 Jun; 40(6):1355-1371. PubMed ID: 35764755
[TBL] [Abstract][Full Text] [Related]
12. Application of a mixture DOE for the prediction of formulation critical temperatures during lyophilisation process optimisation.
Gervasi V; Cullen S; McCoy T; Crean A; Vucen S
Int J Pharm; 2019 Dec; 572():118807. PubMed ID: 31678526
[TBL] [Abstract][Full Text] [Related]
13. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
Stärtzel P
J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
[TBL] [Abstract][Full Text] [Related]
14. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of protein stability in rod-insert vaginal rings.
Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
[TBL] [Abstract][Full Text] [Related]
16. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation.
Kumar V; Sharma VK; Kalonia DS
Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225
[TBL] [Abstract][Full Text] [Related]
17. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
18. Significant Drying Time Reduction Using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.
Gitter JH; Geidobler R; Presser I; Winter G
J Pharm Sci; 2018 Oct; 107(10):2538-2543. PubMed ID: 29890173
[TBL] [Abstract][Full Text] [Related]
19. Lack of a synergistic effect of arginine-glutamic acid on the physical stability of spray-dried bovine serum albumin.
Reslan M; Demir YK; Trout BL; Chan HK; Kayser V
Pharm Dev Technol; 2017 Sep; 22(6):785-791. PubMed ID: 27194596
[TBL] [Abstract][Full Text] [Related]
20. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
